cetylpyridinium chloride anhydrous has been researched along with Liver Cirrhosis, Biliary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alyea, EP; Bellucci, R; Gallagher, M; Gershwin, ME; Li, S; Munshi, NC; Oertelt, S; Porcheray, F; Ritz, J; Soiffer, RJ; Weller, E; Zorn, E | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Liver Cirrhosis, Biliary
Article | Year |
---|---|
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
Topics: Aged; Antibodies; Cell Line, Tumor; Dihydrolipoyllysine-Residue Acetyltransferase; Epitope Mapping; Female; Health; Hematopoietic Stem Cell Transplantation; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondrial Proteins; Paraproteinemias; Transplantation, Homologous | 2007 |